Associations between drug use patterns and viral load suppression among HIV-positive individuals who use support services in New York City

Drug Alcohol Depend. 2019 Apr 1:197:15-21. doi: 10.1016/j.drugalcdep.2018.12.015. Epub 2019 Jan 15.

Abstract

Background: Drug use (DU) represents a significant barrier to maintaining physical health among people living with HIV (PLWH). Few studies, however, have examined the relationship between DU over time and HIV treatment outcomes. Such studies are needed because an individual's risk of poor health outcomes may vary with their DU behaviors. We examined associations between DU patterns over time and unsuppressed viral load (VL).

Methods: The sample included 7896 PLWH in New York City who completed ≥3 substance use assessments over a 24-month period. DU was defined as crystal methamphetamine, crack/cocaine, heroin, and/or recreational prescription medication use in the last three months. Four behavior patterns were constructed: (1) persistent use (DU reported on each assessment); (2) intermittent use-active (DU reported on the third, but not all previous assessments); (3) intermittent use-inactive (DU reported previously with no DU reported on the third assessment); (4) persistent non-use (no DU reported on any assessment). Unsuppressed VL (>200 copies/mL) was assessed based on the last VL value in the New York City HIV Surveillance Registry in the 12 months following an individual's third DU assessment.

Results: Compared with persistent non-users, individuals with intermittent use-inactive (aOR = 1.24, 95% CI = 1.03-1.49), intermittent use-active (aOR = 1.68, 95% CI = 1.36-2.06), and persistent use (aOR = 2.21, 95% CI = 1.69-2.89) were significantly more likely to have unsuppressed VL.

Conclusions: While providers may be more likely to intervene with persistent or active drug users, our findings suggest the importance of addressing the risk of poor HIV treatment outcomes among those with any DU behavior.

Keywords: Drug use; HIV; Patterns; Viral load suppression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Female
  • HIV Infections / blood*
  • HIV Infections / drug therapy
  • HIV Infections / psychology
  • HIV*
  • Humans
  • Male
  • Middle Aged
  • New York City / epidemiology
  • Registries
  • Substance-Related Disorders / epidemiology*
  • Substance-Related Disorders / virology
  • Treatment Outcome
  • Viral Load*

Substances

  • Antiviral Agents